May Orfali - 29 Nov 2021 Form 3 Insider Report for Sigilon Therapeutics, Inc.

Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Nov 2021
Net transactions value
$0
Form type
3
Filing time
01 Dec 2021, 15:44:12 UTC
Next filing
01 Dec 2021

No securities are beneficially owned.